News

Alternatives to HRT used by half in menopause

07-Jun-07

Nearly half of all postmenopausal women seek alternative therapies to HRT, despite admitting to not knowing enough about them, a UK survey has revealed.

Only 20 per cent of surveyed postmenopausal women reported discussing sexual health issues with their GP.

A survey by the Royal Society of Medicine assessed more than 1,000 responses from women on the risks of HRT, use of alternative therapies and sexual health.

According to the survey, 40 per cent of women had used alternative menopause treatments rather than HRT, even though 85 per cent of them said that they did not know enough about the alternative therapies.

A third of respondents said that they thought HRT risks had been exaggerated by the media.

sanjay.tanday@haymarket.com

Menopause International 2007; 13: 79-83

What do you think? Comment below or email us at healthcare.republic@haymarket.com  

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Nursing Professional Issues

Teamworking and the law

Working in teams raises some specific medico-legal issues, writes Sue Parker. Read More

Sunburn - Protecting children against skin cancer

Nurses have helped develop an education programme to promote sun protection, writes Sarah Wild. Read More

Forging partnerships with older people

Nurses are playing an integral role in the Partnerships for Older People Projects programme, writes ... Read More

Show all articles

Latest Clinical Articles

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Clinical Review - Headache in children

Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more

Carpal tunnel syndrome

Section 1: Epidemiology and aetiology Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week